Rifaximin Reduces Endotoxemia and Improves Liver Function and Disease Severity in Patients With Decompensated Cirrhosis
Authors:
- Epameinondas V. TsianosETEpameinondas V. Tsianos
Open Access
- 26 October 2011
- journal article
- other
- Published by Wolters Kluwer Health in Hepatology
- Vol. 55 (2) , 655-656
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The Role of Intestinal Endotoxin in Liver Injury: A Long and Evolving HistoryHepatology, 2010
- Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseasesCurrent Opinion in Gastroenterology, 2010
- The effect of probiotics on gut flora, level of endotoxin and Child–Pugh score in cirrhotic patients: results of a double-blind randomized studyEuropean Journal of Gastroenterology & Hepatology, 2007
- Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosisHepatology, 2004
- Long-Term Treatment With Cisapride and Antibiotics in Liver Cirrhosis: Effect on Small Intestinal Motility, Bacterial Overgrowth, and Liver FunctionAmerican Journal of Gastroenterology, 2001
- Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosisHepatology, 1988